Epstein Secrets

oderate or marked Titer Specimen ID: 104364919 Date Of Report: 09/80/2017 11:30 Date Collected:OE/30/2017 11:53 Date Received: 00/3e/2017 23:12 North America Eastern Time J Antibodies To Association Frequency ate Screening test for SLI In symptomatic patients. (Antinuclear Ab, 95.100% BioReference

ID: Address:9 EAST 71ST STREET, NEw YORK, NY 20021 This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleared or approved by the US Food and Drug Administration. This assay has been validated pursuant to the CLIA regulation

or Dereatteyositis• IIIII Specimen ID: 104364919 Date Of Report: 09/08/2017 11:30 Date Collected:08/30/2017 11:58 Date Received: 08/30/2017 23:12 North America fasten, rime 6e -SON 40-78% 38.80% Antibodies to specific (Extractable) Nuclear Antigens (ENA)/Proteins dsONA Sm(Smith) SS A (R0) 55 8 (La)

ID: Address:9 EAST 7157 STREET, rev YORK, NY 20021 This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleaned or approved by the US Food and Drug Administration. This assay has been validated pursuant to the CLIA regulation

: NCN FASTING S A 0 Specimen IR: 104659439 Date Of Report: 89/21/2017 10:08 Date Collected: 09/15/2017 08:57 Date Received: 09/15/2017 23:06 North America Eastern Ttnie NOTE: SST tube submitted was inadequately spun. Serum was found to contain RBCs. Certain tests, e.g. Glucose, may be decreased while

08/30/2017 '08/30/aiii'l. • titer 1:64 g titer This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleared or approved by the US Food and Drug Administration. This assay has been validated pursuant to the CLIA regulation